img

Global Huntington’s Disease Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Huntington’s Disease Treatment Market Research Report 2024

Medications for movement disorders. Drugs to treat movement disorders include the followingTetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
According to MRAResearch’s new survey, global Huntington’s Disease Treatment market is projected to reach US$ 1532.3 million in 2033, increasing from US$ 225.2 million in 2022, with the CAGR of 30.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Huntington’s Disease Treatment market research.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Huntington’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Segment by Type
Symptomatic Therapy
Disease-Modifying Therapy

Segment by Application


Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Huntington’s Disease Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Symptomatic Therapy
1.2.3 Disease-Modifying Therapy
1.3 Market by Application
1.3.1 Global Huntington’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Huntington’s Disease Treatment Market Perspective (2018-2033)
2.2 Huntington’s Disease Treatment Growth Trends by Region
2.2.1 Global Huntington’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Huntington’s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Huntington’s Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Huntington’s Disease Treatment Market Dynamics
2.3.1 Huntington’s Disease Treatment Industry Trends
2.3.2 Huntington’s Disease Treatment Market Drivers
2.3.3 Huntington’s Disease Treatment Market Challenges
2.3.4 Huntington’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntington’s Disease Treatment Players by Revenue
3.1.1 Global Top Huntington’s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Huntington’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Huntington’s Disease Treatment Revenue
3.4 Global Huntington’s Disease Treatment Market Concentration Ratio
3.4.1 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntington’s Disease Treatment Revenue in 2022
3.5 Huntington’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Huntington’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Huntington’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntington’s Disease Treatment Breakdown Data by Type
4.1 Global Huntington’s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Huntington’s Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Huntington’s Disease Treatment Breakdown Data by Application
5.1 Global Huntington’s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Huntington’s Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Huntington’s Disease Treatment Market Size (2018-2033)
6.2 North America Huntington’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Huntington’s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Huntington’s Disease Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Huntington’s Disease Treatment Market Size (2018-2033)
7.2 Europe Huntington’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Huntington’s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Huntington’s Disease Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Huntington’s Disease Treatment Market Size (2018-2033)
8.2 Asia-Pacific Huntington’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Huntington’s Disease Treatment Market Size (2018-2033)
9.2 Latin America Huntington’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Huntington’s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Huntington’s Disease Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Huntington’s Disease Treatment Market Size (2018-2033)
10.2 Middle East & Africa Huntington’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Huntington’s Disease Treatment Introduction
11.1.4 Bausch Health Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.1.5 Bausch Health Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Introduction
11.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Wave Life Sciences
11.3.1 Wave Life Sciences Company Detail
11.3.2 Wave Life Sciences Business Overview
11.3.3 Wave Life Sciences Huntington’s Disease Treatment Introduction
11.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.3.5 Wave Life Sciences Recent Development
11.4 Ionis Pharmaceuticals/ Roche
11.4.1 Ionis Pharmaceuticals/ Roche Company Detail
11.4.2 Ionis Pharmaceuticals/ Roche Business Overview
11.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Introduction
11.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.4.5 Ionis Pharmaceuticals/ Roche Recent Development
11.5 Raptor Pharmaceuticals
11.5.1 Raptor Pharmaceuticals Company Detail
11.5.2 Raptor Pharmaceuticals Business Overview
11.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Introduction
11.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.5.5 Raptor Pharmaceuticals Recent Development
11.6 Prana Biotechnology
11.6.1 Prana Biotechnology Company Detail
11.6.2 Prana Biotechnology Business Overview
11.6.3 Prana Biotechnology Huntington’s Disease Treatment Introduction
11.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2018-2023)
11.6.5 Prana Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Huntington’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Symptomatic Therapy
Table 3. Key Players of Disease-Modifying Therapy
Table 4. Global Huntington’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Huntington’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Huntington’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Huntington’s Disease Treatment Market Share by Region (2018-2023)
Table 8. Global Huntington’s Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Huntington’s Disease Treatment Market Share by Region (2024-2033)
Table 10. Huntington’s Disease Treatment Market Trends
Table 11. Huntington’s Disease Treatment Market Drivers
Table 12. Huntington’s Disease Treatment Market Challenges
Table 13. Huntington’s Disease Treatment Market Restraints
Table 14. Global Huntington’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Huntington’s Disease Treatment Market Share by Players (2018-2023)
Table 16. Global Top Huntington’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington’s Disease Treatment as of 2022)
Table 17. Ranking of Global Top Huntington’s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Huntington’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Huntington’s Disease Treatment Product Solution and Service
Table 21. Date of Enter into Huntington’s Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Huntington’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Huntington’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Huntington’s Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Huntington’s Disease Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Huntington’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Huntington’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Huntington’s Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Huntington’s Disease Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Huntington’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Huntington’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Huntington’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Huntington’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Huntington’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Huntington’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Huntington’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Huntington’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Huntington’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Huntington’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Huntington’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bausch Health Company Detail
Table 47. Bausch Health Business Overview
Table 48. Bausch Health Huntington’s Disease Treatment Product
Table 49. Bausch Health Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 50. Bausch Health Recent Development
Table 51. Teva Pharmaceuticals Company Detail
Table 52. Teva Pharmaceuticals Business Overview
Table 53. Teva Pharmaceuticals Huntington’s Disease Treatment Product
Table 54. Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 55. Teva Pharmaceuticals Recent Development
Table 56. Wave Life Sciences Company Detail
Table 57. Wave Life Sciences Business Overview
Table 58. Wave Life Sciences Huntington’s Disease Treatment Product
Table 59. Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 60. Wave Life Sciences Recent Development
Table 61. Ionis Pharmaceuticals/ Roche Company Detail
Table 62. Ionis Pharmaceuticals/ Roche Business Overview
Table 63. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product
Table 64. Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 65. Ionis Pharmaceuticals/ Roche Recent Development
Table 66. Raptor Pharmaceuticals Company Detail
Table 67. Raptor Pharmaceuticals Business Overview
Table 68. Raptor Pharmaceuticals Huntington’s Disease Treatment Product
Table 69. Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 70. Raptor Pharmaceuticals Recent Development
Table 71. Prana Biotechnology Company Detail
Table 72. Prana Biotechnology Business Overview
Table 73. Prana Biotechnology Huntington’s Disease Treatment Product
Table 74. Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 75. Prana Biotechnology Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Huntington’s Disease Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Huntington’s Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. Symptomatic Therapy Features
Figure 4. Disease-Modifying Therapy Features
Figure 5. Global Huntington’s Disease Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Huntington’s Disease Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Huntington’s Disease Treatment Report Years Considered
Figure 10. Global Huntington’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Huntington’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Huntington’s Disease Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Huntington’s Disease Treatment Market Share by Players in 2022
Figure 14. Global Top Huntington’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington’s Disease Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Huntington’s Disease Treatment Revenue in 2022
Figure 16. North America Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Huntington’s Disease Treatment Market Share by Country (2018-2033)
Figure 18. United States Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Huntington’s Disease Treatment Market Share by Country (2018-2033)
Figure 22. Germany Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Huntington’s Disease Treatment Market Share by Region (2018-2033)
Figure 30. China Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Huntington’s Disease Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Huntington’s Disease Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Huntington’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Bausch Health Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 45. Teva Pharmaceuticals Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 46. Wave Life Sciences Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 47. Ionis Pharmaceuticals/ Roche Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 48. Raptor Pharmaceuticals Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 49. Prana Biotechnology Revenue Growth Rate in Huntington’s Disease Treatment Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed